SPARC and neoplasm: As Zhang et al. (2012) and Zhang et al. (2014) reported, “SPARC expression is negatively correlated with the clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells,” and they confirmed the anti-tumor activity of SPARC in vivo and in vitro.